Drugs / Idrabiotaparinux sodium
Idrabiotaparinux sodium
also known as
Idrabiotaparinux · Idrabiotaparinux sodico · Idrabiotaparinux sodique · Ssr-126517 sodium · SSR126517E
targets F10 via inhibition
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00580216 | Dec 2007 → Oct 2010 | atrial fibrillation | Sanofi | Terminated | No outcome recorded Stop: Business |
| Phase 3 | NCT00345618 | Jun 2006 → Oct 2010 | pulmonary embolism, venous thromboembolism | Sanofi | Completed | Met primary |
| Phase 3 | NCT00311090 | Apr 2006 → Jan 2008 | venous thromboembolism | Sanofi | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Idrabiotaparinux sodium | “Objectives are to evaluate whether idrabiotaparinux sodium (SSR126517E) is as least as effective as a standard warfarin treatment to prevent recurrence of venous thromboembolic...” NCT00345618 ↗1“once weekly subcutaneous (SC) injection of idrabiotaparinux sodium (biotinylated idraparinux)” NCT00580216 ↗ |
| Known as | Idrabiotaparinux | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00311090 ↗ |
| Known as | Idrabiotaparinux sodico | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297768 ↗ |
| Known as | Idrabiotaparinux sodique | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297768 ↗ |
| Known as | Ssr-126517 sodium | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297768 ↗ |
| Known as | SSR126517E | “Objectives are to evaluate whether idrabiotaparinux sodium (SSR126517E) is as least as effective as a standard warfarin treatment to prevent recurrence of venous thromboembolic...” NCT00345618 ↗ |
| Action | Inhibit | “Idrabiotaparinux has a similar time course of FXa inhibition, efficacy and safety to idraparinux for the treatment of deep venous thrombosis.” PMID 20946157 ↗ Jan 20111“Coagulation factor X inhibitor” CHEMBL4297768 ↗ |
| Route | Subcutaneous | “both given subcutaneously” PMID 20946157 ↗ Jan 2011 |
| Target | F10 | “Coagulation factor X inhibitor” CHEMBL4297768 ↗ |